Atea showcased its Phase III HCV programme at JPM for bemnifosbuvir/ruzasvir, positioning the regimen for test-and-treat ...
Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In this video, Paul Kwo, MD, professor of medicine and director of hepatology at Stanford ...
People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...
MAVIRET is the first and only oral eight-week pan-genotypic treatment option approved for people with acute or chronic ...
People with opioid use disorder (OUD) who have hepatitis C virus (HCV) were twice as likely to be treated and cured of HCV if they received facilitated telemedicine treatment within their opioid ...
People with opioid use disorder who have hepatitis C virus (HCV) were twice as likely to be successfully treated and cured from HCV if they received facilitated telemedicine treatment at their opioid ...
BUFFALO, N.Y. – Telemedicine is widely perceived as an important tool for potentially improving health care access for the underserved. However, few randomized controlled trials have been conducted to ...
As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback